Levi Strauss & Co. SEC Filings

LEVI STRAUSS & CO (LEVI) reported a Form 144 notice for the proposed sale of 4,395 Class A shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $105,480. The shares were acquired mainly through restricted stock vesting in 2024 as compensation, in tranches of 520, 2,962, 720 and 193 shares between January and July 2024. The filer represents they are unaware of any undisclosed material adverse information and indicates prior sales by the same person totaling 3,629 shares on 07/11/2025 that generated gross proceeds of $79,838. The notice lists the broker, planned approximate sale date of 10/01/2025, and confirms the holdings outstanding at 107,206,840 shares.

Margaret E. Haas, a director of Levi Strauss & Co., reported conversions of Class B common stock into Class A on 04/15/2025 and 08/11/2025, converting 133,443 and 209,450 shares respectively. Each Class B share is convertible into one share of Class A and has no expiration.

The filing also shows private sales of 16,273 and 25,723 Class B shares at prices of $14.72 and $20.07. Reported direct beneficial ownership following the April transactions was 13,610,828 shares and following the August transactions was 13,375,655; reported indirect holdings were 21,109,593 and 21,319,043. Footnotes state many shares are held in trusts and charitable entities and that Ms. Haas disclaims beneficial ownership of certain shares held for others.

Capital Research Global Investors filed a Schedule 13G reporting its position in Levi Strauss & Co. common stock as a beneficial owner of 0 shares, representing 0.0% of the 104,585,522 shares the filing states are outstanding. The filing identifies CRGI as an investment adviser division of Capital Research and Management Company and related investment management entities and states that, collectively under the name Capital Research Global Investors, they are deemed to beneficially own 0 shares.

The filing shows 0 sole and 0 shared voting powers and 0 sole and 0 shared dispositive powers, and includes a certification that the securities (if any) are held in the ordinary course of business and not to influence control of the issuer.

Prime Joshua E, identified as a director of Levi Strauss & Co. (LEVI), acquired 137 dividend equivalent rights (DERs) on 08/08/2025 at a reported price of $0.00. Those DERs are contingent rights to receive one share of the companys Class A Common Stock upon settlement and vest in line with the underlying awards.

The filing shows 64,570 Class A shares beneficially owned by the reporting person following the transaction, held directly. Unvested DERs vest 100% on the earlier of the day before the next annual meeting or one year after grant; some underlying awards are already vested but subject to deferred delivery, with the same DER terms.

Patrick Artemis, a director of Levi Strauss & Co., reported the acquisition of 97 dividend equivalent rights (DERs) tied to Class A Common Stock on 08/08/2025, increasing his direct beneficial ownership to 14,076 shares. The DERs are contingent rights to receive one share each upon settlement and vest consistent with the underlying awards; unvested awards and related DERs accelerate to 100% vesting on the earlier of the day before the next annual meeting or the first anniversary of grant. Some underlying awards are fully vested but subject to a deferred delivery feature, which also applies to the related DERs.

Ming Jenny J, a director of Levi Strauss & Co. (LEVI), reported insider acquisitions on 08/08/2025 consisting of dividend equivalent rights (DERs) tied to the company's common stock. The filing shows the reporting person acquired 82 DERs that represent contingent rights to receive Class A common stock and 110 DERs that represent contingent rights to receive Class B common stock; the Class B DERs are noted as fully vested and subject to a deferral delivery feature. The report lists 64,442 shares of Class A common stock beneficially owned following the non-derivative transaction and 59,775 derivative securities beneficially owned following the reported derivative transaction. Each share of Class B common stock is convertible into one share of Class A common stock per the filing.

Christopher J. McCormick, a director of Levi Strauss & Co. (LEVI), reported awards and related contingent dividend-equivalent rights on 08/08/2025. The filing shows the acquisition of 213 dividend equivalent rights (DERs) tied to Class A Common Stock and 41 DERs tied to Class B Common Stock, both reported as acquired at a $0.00 price. After these transactions, the report lists 70,103 shares of Class A Common Stock and 57,464 shares (or equivalents) of Class A Common Stock underlying Class B holdings as beneficially owned directly. The DERs vest and settle consistent with underlying awards; unvested awards vest on the earlier of the day before the next annual meeting or one year after grant, and some DERs are fully vested but subject to deferred delivery.